IQGAP2 rs3797418: What Your Genotype Means
The rs3797418 variant is a single nucleotide polymorphism located within the IQGAP2 gene. Research has identified this variant as being associated with variations in gene expression and altered sensitivity to specific chemotherapeutic agents, such as gemcitabine and cytarabine.
What each genotype means
Typical drug sensitivity
This genotype represents the common baseline for the IQGAP2 variant rs3797418. Research indicates that individuals with this genotype do not carry the specific variation associated with altered sensitivity to chemotherapeutic agents like gemcitabine and cytarabine. Please discuss all chemotherapy dosing and treatment plans with your oncologist or pharmacist.
This is a common genotype observed across diverse global populations.
Potential altered drug sensitivity
This genotype includes one copy of the variant associated with changes in gene expression and altered sensitivity to gemcitabine and cytarabine. While the clinical impact of carrying a single copy is not fully established, research suggests this variant may influence how your body responds to these specific medications. Always consult your clinician or pharmacist regarding personalized dosing or treatment adjustments.
This heterozygous genotype is commonly observed in diverse populations.
Potential altered drug sensitivity
This genotype includes two copies of the variant associated with changes in gene expression and altered IC50 sensitivity to chemotherapeutic agents like gemcitabine and cytarabine. Research has linked this variant to variations in drug response, though individual clinical outcomes can vary significantly. Please discuss your specific treatment profile and medication sensitivity with your oncology team.
This genotype is found at varying frequencies across different ancestral groups.
Understanding the rs3797418 Variant
The rs3797418 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located in the intronic region of the IQGAP2 gene. Introns are non-coding segments of DNA that sit between the coding sequences of a gene. While they do not provide the direct instructions for building proteins, they often play critical roles in regulating how genes are turned on or off. Because rs3797418 is situated within this regulatory landscape, researchers have investigated whether it influences the activity levels of IQGAP2 and other nearby genes. Genetic variants like this are common in the human genome, and they serve as markers that scientists use to understand how subtle differences in our DNA sequence can lead to biological variation between individuals.
The Role of the IQGAP2 Gene
The IQGAP2 gene encodes a protein known as IQ motif containing GTPase activating protein 2. This protein is part of a family of scaffold proteins that help organize the internal structure of cells and facilitate communication between different cellular components. By interacting with various signaling molecules, IQGAP2 plays a role in processes such as cell migration, adhesion, and the regulation of the cytoskeleton. Because these processes are fundamental to how cells grow and divide, the function of IQGAP2 is of significant interest in cancer research. Understanding how this gene operates helps scientists map out the complex pathways that cancer cells use to survive and how those pathways might be influenced by genetic variations that alter gene expression.
Research and Pharmacogenomic Associations
Scientific research has identified a statistical association between the rs3797418 variant and the sensitivity of cells to certain chemotherapy drugs, specifically gemcitabine and cytarabine. Studies have observed that this variant correlates with changes in the IC50, which is a measure of the concentration of a drug required to inhibit a biological process by 50%. Essentially, the presence of this variant has been linked to differences in how effectively these drugs can inhibit cell growth in laboratory models. It is important to note that the evidence for this association is considered moderate. While these findings provide valuable insights into potential biomarkers for drug response, they are primarily derived from experimental studies. Further research is required to fully understand the clinical implications of this variant in diverse patient populations.
What This Information Means for You
It is essential to understand that genetic associations are statistical observations made across groups of people and do not serve as a diagnostic tool for any individual. Having a specific genotype for rs3797418 does not guarantee a particular response to medication, nor does it predict a specific health outcome. Pharmacogenomics is a complex field where many factors—including other genetic variants, environmental influences, and overall health status—contribute to how a person responds to treatment. If you are undergoing medical treatment or have questions about how your genetic profile might influence your response to specific medications, you should discuss this information directly with your clinician or pharmacist. They are the best resources to help you interpret your health data in the context of your personal medical history and current treatment plan.
How common is this variant?
The rs3797418 variant is commonly observed across diverse human populations, with various genotypes appearing at different frequencies depending on ancestral background.
Frequently asked questions
Can I use this information to predict my response to chemotherapy?
No. Genetic variants like rs3797418 are only one of many factors that influence how a person responds to medication. You should never make decisions about your medical treatment based on genetic data without consulting your healthcare provider.
Is rs3797418 a diagnostic test for cancer?
No. This variant is a research-level marker associated with gene expression and drug sensitivity in laboratory studies. It is not used as a diagnostic tool for identifying or screening for cancer.
Where can I find more information about my specific genotype?
If you have received genetic testing results, you should review them with a qualified genetic counselor or your primary care physician. They can help you understand the clinical relevance, if any, of your specific results.
Why is the evidence for this variant considered moderate?
Evidence is labeled as moderate when findings are based on significant statistical associations in research studies but have not yet been widely validated in large-scale clinical trials or established as standard clinical practice.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3797418?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29